Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer ...
Not long after President Trump made his statement, Kenvue and Johnson & Johnson got into another complicated legal mess when ...
(Reuters) -Kleenex maker Kimberly-Clark said on Monday it will buy Kenvue for more than $40 billion in a landmark deal for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results